135 related articles for article (PubMed ID: 31345745)
1. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
[TBL] [Abstract][Full Text] [Related]
3. Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi.
Martín-Escolano R; Moreno-Viguri E; Santivañez-Veliz M; Martin-Montes A; Medina-Carmona E; Paucar R; Marín C; Azqueta A; Cirauqui N; Pey AL; Pérez-Silanes S; Sánchez-Moreno M
J Med Chem; 2018 Jul; 61(13):5643-5663. PubMed ID: 29883536
[TBL] [Abstract][Full Text] [Related]
4. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives.
Paucar R; Martín-Escolano R; Moreno-Viguri E; Cirauqui N; Rodrigues CR; Marín C; Sánchez-Moreno M; Pérez-Silanes S; Ravera M; Gabano E
Eur J Med Chem; 2019 Feb; 163():569-582. PubMed ID: 30554132
[TBL] [Abstract][Full Text] [Related]
5. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
[TBL] [Abstract][Full Text] [Related]
7. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease.
Beltran-Hortelano I; Atherton RL; Rubio-Hernández M; Sanz-Serrano J; Alcolea V; Kelly JM; Pérez-Silanes S; Olmo F
Eur J Med Chem; 2021 Nov; 223():113646. PubMed ID: 34182359
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
11. Hit-to-lead optimization of novel 2-alkylaminomethylquinoline derivatives as anti-chagas agents.
Muscia GC; Roldán Pacheco FJ; Asís SE; Buldain GY; Frank FM
Eur J Med Chem; 2020 Jan; 186():111877. PubMed ID: 31771829
[TBL] [Abstract][Full Text] [Related]
12. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
13. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins.
Robledo-O'Ryan N; Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Moncada-Basualto M; Mura F; Lapier M; Maya JD; Olea-Azar C
Bioorg Med Chem; 2017 Jan; 25(2):621-632. PubMed ID: 27908757
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
[TBL] [Abstract][Full Text] [Related]
18. A structure-based approach towards the identification of novel antichagasic compounds:
Llanos MA; Sbaraglini ML; Villalba ML; Ruiz MD; Carrillo C; Alba Soto C; Talevi A; Angeli A; Parkkila S; Supuran CT; Gavernet L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):21-30. PubMed ID: 31619095
[No Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model.
Martín-Escolano R; Marín C; Vega M; Martin-Montes Á; Medina-Carmona E; López C; Rotger C; Costa A; Sánchez-Moreno M
Bioorg Med Chem; 2019 Mar; 27(5):865-879. PubMed ID: 30728107
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
